News
The decision not to fund Elaprase was based on clinical appropriateness and cost-effectiveness as well as the PMB Code of ...
The board of directors of MTNZF is pleased to advise that at a meeting held on 4 July 2025, the directors approved the declaration of a gross cash distribution by way of a return of CTC from income re ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results